Yinglian Xiao, Jiaming Qian, Shutian Zhang, Ning Dai, Hoon Jai Chun, Chengtang Chiu, Chui Fung Chong, Nobuo Funao, Yuuichi Sakurai, Jessica D Eisner, Li Xie, Minhu Chen
BACKGROUND: Erosive esophagitis (EE) is a gastroesophageal reflux disease characterized by mucosal breaks in the esophagus. Proton pump inhibitors are widely used as maintenance therapy for EE, but many patients still relapse. In this trial, we evaluated the noninferiority of vonoprazan vs. lansoprazole as maintenance therapy in patients with healed EE. METHODS: We performed a double-blind, double-dummy, multicenter, phase 3 clinical trial among non-Japanese Asian adults with endoscopically confirmed healed EE from April 2015 to February 2019...
April 20, 2024: Chinese Medical Journal